EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage

Medicine & Life Sciences

• G2 Phase Cell Cycle Checkpoints 70%
• ErbB Receptors 48%
• Nanoparticles 45%
• DNA Damage 44%
• Lung 27%
• Growth 25%
• Apoptosis 17%
• Cell Cycle 17%
• Cell Survival 16%
• Cell Death 16%
• Neoplasms 16%
• G2 Phase 16%
• Autophagy 14%
• Cell Division 13%
• CDC2 Protein Kinase 10%
• Western Blotting 9%
• In Vitro Techniques 9%
• Cell Line 8%
• Therapeutics 8%
• Control Groups 7%
• G1 Phase 7%
• Mitosis 7%
• Histones 6%
• Heterografts 6%
• Fluorescent Antibody Technique 6%
• Therapeutic Uses 6%
• Lung Neoplasms 5%
• Cell Count 5%
• Phosphorylation 5%
• DNA 4%
• Proteins 2%

Engineering & Materials Science

• Plasmonic nanoparticles 100%
• Epidermal Growth Factor 88%
• Magnetic nanoparticles 77%
• Tumors 52%
• Cells 49%
• Cell death 48%
• Heterografts 8%
• Proteins 8%

Chemistry

• Cell Death 54%
• Magnetic Nanoparticle 50%
• Cell Viability 50%
• Western Blotting 43%
• Histone 18%
• Antitumor 15%
• Marker 14%
• Protein 14%
• Cleavage 11%